CVS Health Corporation $CVS Shares Acquired by Sterling Capital Management LLC

Sterling Capital Management LLC boosted its holdings in CVS Health Corporation (NYSE:CVS) by 12.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 128,075 shares of the pharmacy operator’s stock after acquiring an additional 13,948 shares during the period. Sterling Capital Management LLC’s holdings in CVS Health were worth $10,975,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of CVS. BlackRock Inc. acquired a new stake in shares of CVS Health during the second quarter worth $12,747,462,000. State Street Corp lifted its position in shares of CVS Health by 26.3% during the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock worth $7,751,205,000 after buying an additional 15,604,883 shares during the last quarter. Wellington Management Group LLP grew its holdings in shares of CVS Health by 49.8% during the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after purchasing an additional 11,233,381 shares during the last quarter. Bank of America Corp DE lifted its stake in CVS Health by 148.0% in the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after purchasing an additional 13,836,701 shares during the last quarter. Finally, Pzena Investment Management LLC acquired a new position in shares of CVS Health during the second quarter worth $1,217,558,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Analyst price target maintained: Cantor Fitzgerald kept its $110 price target for CVS, implying confidence in further upside from recent trading levels. Cantor Fitzgerald maintains CVS price target
• Positive Sentiment: Expanded fall merchandise: CVS Pharmacy is adding collectibles, limited-edition products, beauty items, snacks and seasonal offerings across stores and CVS.com. The initiative could support front-store traffic and retail sales, although its financial impact is not yet quantified. CVS expands fall assortment
• Positive Sentiment: New clinic openings: CVS reportedly opened three clinics, supporting its broader healthcare-services strategy and potentially increasing patient engagement and revenue opportunities. CVS opens three clinics
• Neutral Sentiment: Unusually high call-option activity: Traders purchased 51,620 call options, about 203% above average. This signals increased speculative interest and may indicate bullish positioning, but options activity alone does not establish a change in CVS’s fundamentals.
• Neutral Sentiment: Analyst attention remains elevated: Zacks highlighted CVS as a heavily watched stock but did not provide a definitive new buy catalyst. Investors continue to weigh the company’s latest strong earnings performance against execution risks in its healthcare businesses. Zacks analysis of CVS
• Negative Sentiment: Recent underperformance: CVS previously declined even as the broader market gained, indicating lingering investor concerns or a lack of a fresh catalyst. The company’s strong latest quarterly results and fiscal 2026 earnings guidance provide support, but investors may remain focused on whether that performance is sustainable.

Analyst Ratings Changes

Several brokerages have recently weighed in on CVS. Leerink Partners decreased their price target on CVS Health from $119.00 to $112.00 and set an “outperform” rating for the company in a research note on Monday, October 12th. Wells Fargo & Company upped their price target on shares of CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. JPMorgan Chase & Co. increased their price target on CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. HSBC reissued a “hold” rating and issued a $103.00 price objective on shares of CVS Health in a research report on Monday, July 6th. Finally, UBS Group reissued a “buy” rating on shares of CVS Health in a research note on Tuesday, September 22nd. Twenty analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $107.80.

CVS Health Stock Down 1.0%

CVS stock traded down $0.94 during trading on Friday, reaching $93.55. The stock had a trading volume of 4,601,538 shares, compared to its average volume of 9,303,546. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $119.64 billion, a price-to-earnings ratio of 24.75, a P/E/G ratio of 0.88 and a beta of 0.60. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The company’s 50 day moving average is $91.60 and its two-hundred day moving average is $93.78.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter last year, the company posted $1.81 earnings per share. The firm’s quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts forecast that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd will be issued a $0.6650 dividend. This represents a $2.66 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Thursday, October 22nd. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

About CVS Health

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.